Special notice
FY26 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science
FDABAA-26-00123
Food and Drug Administration, FDA Office of Acquisitions and Grants Services. Research and Development in Biotechnology (except Nanobiotechnology).
Response deadline
February 24, 2026 at 5:00 PM EST
Closed 250 days ago. Posted January 16, 2026, first published November 21, 2025. Scheduled to archive September 30, 2026.
Get the next one like this from Food and Drug Administration by email, the day it is posted.Find my opportunities
This one closed in 2026
18 like it are open now in research and development in biotechnology (except nanobiotechnology)
- Quantitative Analysis of Longitudinal MR Images
National Institutes of Health, National Institutes of Health Olao
Sources soughtNAICS 541714Bethesda, MD75N98027R00005Closes in 8 daysNov 9 - RFI Lupus Research Program (LRP) Public
Defense Health Agency (Dha), Defense Health Agency
Sources soughtNAICS 541714Frederick, MDHT9427RFI2027LRPCloses in 15 daysNov 16 - RFI Alzheimer’s Research Program (AZRP) Public
Defense Health Agency (Dha), Defense Health Agency
Sources soughtNAICS 541714Frederick, MDHT9427RFI2027AZRPCloses in 33 daysDec 4
All 18 open in research and development in biotechnology (except nanobiotechnology)
Description
As published on SAM.gov.
Amendment 03 - Updated the announcement document to version 2.0. Changes are highlighted throughout the document.
Amendment 02 - Save the date! the FY26 Virtual BAA day - 20 January 2026!
https://www.fda.gov/science-research/advancing-regulatory-science/2026-fda-broad-agency-announcement-day-01202026
Amendment 01 - Updated the announcement document to version 2.0. Changes are highlighted throughout the document.
In accordance with FAR 6.102(d)(2) and 35.016, the US Food and Drug Administration (FDA) solicits for the acquisition of basic and applied research and development proposals to support regulatory science and innovation through this Broad Agency Announcement (BAA). Research and development activities acquired under this BAA are intended to advance scientific knowledge in specific research areas as well as sub areas of interest defined within the BAA that serve the FDA in accomplishing its mission to protect and promote the health of our nation. Proposals submitted under this announcement are not limited solely to the PSC code "AJ11" specified in this announcement.
FDA funds extramural research through an agency-wide Broad Agency Announcement (BAA) for research and development to support regulatory science and innovation.
Attachments
Files listed on SAM.gov. The ones we hold a copy of download from here; the rest open SAM's download, which needs no account.
- Attachment 6 SOW Template.docx15 KB, November 21, 2025
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
November 21, 2025
Special notice
Due February 24, 2026 at 11:59 PM EST. SAM.gov, notice 803a5109fa3c49ebae21c22167a9a8d4
4 revisions on SAM
- January 16, 2026: publish, special notice
- January 6, 2026: publish, special notice
- December 16, 2025: publish, special notice
- November 21, 2025: publish, special notice
December 16, 2025
Special notice
Due February 24, 2026 at 5:00 PM EST. SAM.gov, notice 5f582391365645c2b030260aaf922e8b
4 revisions on SAM
- January 16, 2026: publish, special notice
- January 6, 2026: publish, special notice
- December 16, 2025: publish, special notice
- November 21, 2025: publish, special notice
January 6, 2026
Special notice
Due February 24, 2026 at 5:00 PM EST. SAM.gov, notice fc0fe580a8224192850fdb5f2ac40c4e
4 revisions on SAM
- January 16, 2026: publish, special notice
- January 6, 2026: publish, special notice
- December 16, 2025: publish, special notice
- November 21, 2025: publish, special notice
January 16, 2026
Special notice
Due February 24, 2026 at 5:00 PM EST. SAM.gov, notice 5622acb8db634d37b3b55d607e6ba561
5 revisions on SAM
- October 8, 2026: publish, award notice
- January 16, 2026: publish, special notice
- January 6, 2026: publish, special notice
- December 16, 2025: publish, special notice
- November 21, 2025: publish, special notice
Points of contact
- Ian WeissIan.Weiss@fda.hhs.gov3017965728